Charles Schwab Investment Management Inc Alx Oncology Holdings Inc Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 216,707 shares of ALXO stock, worth $238,377. This represents 0.0% of its overall portfolio holdings.

Number of Shares
216,707
Previous 225,302 3.81%
Holding current value
$238,377
Previous $410,000 11.95%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
$1.21 - $1.87 $10,399 - $16,072
-8,595 Reduced 3.81%
216,707 $361,000
Q3 2024

Nov 12, 2024
SELL
$1.81 - $8.13 $19,399 - $87,137
-10,718 Reduced 4.54%
225,302 $410,000
Q2 2024

Aug 12, 2024
BUY
$5.84 - $17.56 $153,364 - $461,143
26,261 Added 12.52%
236,020 $1.42 Million
Q1 2024

May 08, 2024
BUY
$10.95 - $16.79 $17,465 - $26,780
1,595 Added 0.77%
209,759 $2.34 Million
Q4 2023

Feb 06, 2024
BUY
$4.81 - $15.38 $324,338 - $1.04 Million
67,430 Added 47.91%
208,164 $3.1 Million
Q3 2023

Nov 08, 2023
SELL
$4.19 - $7.35 $103,983 - $182,404
-24,817 Reduced 14.99%
140,734 $675,000
Q2 2023

Aug 09, 2023
BUY
$4.37 - $9.56 $65,895 - $144,155
15,079 Added 10.02%
165,551 $1.24 Million
Q1 2023

May 11, 2023
SELL
$4.52 - $11.71 $42,998 - $111,397
-9,513 Reduced 5.95%
150,472 $680,000
Q4 2022

Feb 13, 2023
BUY
$9.51 - $12.95 $80,673 - $109,854
8,483 Added 5.6%
159,985 $1.8 Million
Q3 2022

Nov 14, 2022
SELL
$8.23 - $15.14 $1,736 - $3,194
-211 Reduced 0.14%
151,502 $1.45 Million
Q2 2022

Aug 15, 2022
BUY
$5.89 - $19.46 $107,398 - $354,833
18,234 Added 13.66%
151,713 $1.23 Million
Q1 2022

May 13, 2022
SELL
$13.65 - $22.06 $87,400 - $141,250
-6,403 Reduced 4.58%
133,479 $2.26 Million
Q4 2021

Feb 11, 2022
BUY
$21.49 - $74.4 $25,272 - $87,494
1,176 Added 0.85%
139,882 $3.01 Million
Q3 2021

Nov 16, 2021
BUY
$52.51 - $80.91 $2.42 Million - $3.72 Million
46,002 Added 49.62%
138,706 $10.2 Million
Q2 2021

Aug 16, 2021
BUY
$52.2 - $75.23 $90,514 - $130,448
1,734 Added 1.91%
92,704 $5.07 Million
Q1 2021

May 17, 2021
BUY
$62.84 - $87.68 $1.19 Million - $1.66 Million
18,939 Added 26.29%
90,970 $6.71 Million
Q4 2020

Feb 16, 2021
BUY
$34.11 - $112.26 $481,189 - $1.58 Million
14,107 Added 24.35%
72,031 $6.21 Million
Q3 2020

Nov 13, 2020
BUY
$29.36 - $47.1 $1.7 Million - $2.73 Million
57,924 New
57,924 $2.19 Million

Others Institutions Holding ALXO

# of Institutions
96
Shares Held
39.5M
Call Options Held
213K
Put Options Held
44.8K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $44.8M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email